E.C.M. RES.:
HCV 2026: Quick Diagnosis,Terapia breve,Accesso universal

15 June 2026
Starhotels RITZ - MILANO

TYPOLOGY

RES

FREE

DATE

15/06/2026

END DATE

15/06/2026
Sign in to join the course

Scientific rationale

The elimination of HCV infection remains a priority goal of public health, in line with the targets set by the WHO for 2030. In Italy, the introduction of free screening for birth cohorts 1969-1989 represented a significant step, but the most recent data show that a significant proportion of patients still escapes diagnosis or, although identified, is not promptly initiated to treatment.

However, in everyday clinical practice, some issues remain open, including therapeutic choice criteria, drug interaction management and multidisciplinary comparison.

This course aims to address these themes from the real data collected through a pre-event survey conducted among participants, to photograph the current methods of screening and treatment on the territory. The survey results, presented and discussed during the meeting, will become the basis for an interactive comparison through roundtables in which to share virtuous experiences of intra-hospital screening and exemplifying clinical cases of the use of short therapy in patients characterized by different profiles.

The training goal is to provide participants with concrete tools to optimize the patient's diagnostic-therapeutic path with hepatitis C, enhancing a rapid, simplified and patient-centered approach.

CONTRIBUTION

 

START
15 June 2026
END OF COURSE
15 June 2026
TYPOLOGY
RES
LOCATION
Starhotels RITZ - Milan
PARTICIPANTS
20
TARGETS
SURRGES

REFERENCE SPIPLINES:
Gastroenterology, Epathology, Infectious DiseasesOncology
ECM ID
752 - 483704
N. CREDITS RES
6,5
REGISTERING QUOTA
Free
E-MAIL
info@studio-congressi.com
Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00